A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's
Saved in:
| Title: | A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's |
|---|---|
| Authors: | Tornling, G, Edenius, C, Pauling, JD, Denton, CP, Olsson, A, Kowalski, J, Murray, A, Anderson, M, Bhat, S, Del, Galdo F |
| Source: | RHEUMATOLOGY. 64(2):704-713 |
| Access URL: | http://kipublications.ki.se/Default.aspx?queryparsed=id:154970472 |
| Database: | SwePub |
| ISSN: | 14620324 |
|---|---|
| DOI: | 10.1093/rheumatology/keae049 |
Full Text Finder
Nájsť tento článok vo Web of Science